TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ALKS

Alkermes Plc

Healthcare · Drug Manufacturers - Specialty & Generic

46.70$ +1.4% vs. previous close Closing price · As of: Sep 17, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Alkermes Plc (ALKS) with date, type and a link to the original document.

Filings ALKS
Date Type Filing Original
09/16/2026 Current report (8-K) Alkermes plc. (ALKS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits View report ↗
09/03/2026 Insider sale notice Form 144 filed with the SEC View document ↗
09/01/2026 Insider sale notice Form 144 filed with the SEC View document ↗
08/17/2026 Insider sale notice Form 144 filed with the SEC View document ↗
08/12/2026 Current report (8-K) Alkermes plc. (ALKS): Entry into a Material Definitive Agreement; Financial Statements and Exhibits View report ↗
08/03/2026 Insider sale notice Form 144 filed with the SEC View document ↗
08/03/2026 Insider sale notice Form 144 filed with the SEC View document ↗
08/03/2026 Insider sale notice Form 144 filed with the SEC View document ↗
07/28/2026 Current report (8-K) Alkermes plc. (ALKS): Results of Operations and Financial Condition; Financial Statements and Exhibits View report ↗
07/08/2026 Current report (8-K) Alkermes plc. (ALKS): Termination of a Material Definitive Agreement View report ↗
07/06/2026 Insider sale notice Form 144 filed with the SEC View document ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?